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Toxicoproteomics is the use of global pro-
tein expression technologies to better
understand environmental and genetic fac-
tors, both in episodes of acute exposure to
toxicants and in the long-term develop-
ment of disease. Integrating transcript,
protein, and toxicology data is a major
objective of the field of toxicogenomics.
Toward that goal, the NCT is pursuing a
strategy of conducting parallel DNA
microarray and proteomic analyses on the
same tissues from each toxicogenomics
study. This parallel approach combines the
high level of gene discovery of microarray
analysis with the utility of proteomics in
exploiting post-translational modifications
of target proteins affected by toxicants to
identify biomarkers. 
The Proteomics Program within the
NCT consists of an intramural program, a
proteomics resource contract, extramural
awards in proteomics, and Small Business
Innovation Research awards. The close
association of the Proteomics Program
with the NIEHS Microarray Center and
interactions with the National Toxicology
Program also provide unique opportunities
for integrating genomics, proteomics, and
toxicology into joint studies.
Methods
A primary goal of the intramural program
is the discovery of biomarkers in organs
and serum that reflect toxicant exposure or
environmental disease, using both estab-
lished and emerging proteomics technolo-
gies. For example, two-dimensional gel
electrophoresis and MS/MS are being used
for global protein separation and protein
identification. SELDI is being investigated
for potential use in serum biomarker devel-
opment and classification of control and
toxicant-exposed experimental animals.
Strong capabilities have been built in capil-
lary and nanoscale LC separations and in
the use of MS for the identification and
fine structure characterization of protein
samples digested by enzymes. There is also
an emphasis on LC/MS/MS approaches to
differential protein expression, such as the
use of isotope-coded affinity tags and char-
acterization of post-translational modifica-
tions. Additional capabilities include
MALDI/TOF/MS, MALDI/TOF/TOF
MS/MS, nanoscale LC/ESI/Q-Tof
MS/MS, N- and C-terminal protein
microsequencing, several capillary HPLCs,
a proteomics laboratory information man-
agement system, and a National Center for
Biotechnology Information database with
search capabilities that is housed on cam-
pus. Efforts in this area are coordinated by
two research groups, the NCT Proteomics
Group and the Mass Spectrometry Group
in the NIEHS Laboratory of Structural
Biology.
Investigations
Researchers in the Proteomics Program are
particularly interested in investigating protein
phosphorylation as a key post-translational
event in pathway signaling and in protein
degradation. New fluorescent phosphoryla-
tion sensor dyes, IMAC techniques, and site-
specific phosphopeptide biotinylation are
three new procedures being used to detect
and capture large numbers of phosphorylated
proteins and peptides simultaneously.
Further, MALDI/MS and LC/MS/MS tech-
niques are being used to identify changes
in phosphopeptides altered by exposure to
toxicants.
Investigation of cellular and subcellu-
lar proteomes is another area in which
NCT researchers are exploiting toxicopro-
teomics. Although most tissues are
amenable to RNA extraction for genera-
tion of cDNA and hybridization to thou-
sands of genes arrayed on DNA chips,
protein analysis often involves reductive
procedures whereby the complex structure
of organs is lost. NCT researchers are
retaining a certain level of organization by
isolating specialized cell types within the
organ and fractionating organs into sub-
cellular components and organelles.
Because liver tissue can be analyzed
whole or as subcellular fractions, these
techniques are being used to investigate
liver toxicity. 
Although the liver consists primarily
of hepatic parenchymal cells, several
nonparenchymal cells—including stellate
cells, pit cells, Kupffer cells, biliary cells,
and endothelial cells—also are important
for liver function. These cells may be tar-
gets for toxicity and may increase in
number in some toxic and pathologic
conditions to significantly alter the
hepatic protein profile. Isolation of these
cells in their resting and active states may
reveal protein profiles contributing to
liver toxicity that would have been very
difficult to observe in a mixed popula-
tion of cells dominated by hepatocytes. 
Fractionation of subcellular organelles
is a means to enrich for structurally
meaningful subcellular units of the liver
in a way that is not possible by protein
analysis of whole liver homogenates or
even by RNA isolation and transcript
analysis. Enriched fractions of nuclei,
mitochondria, endoplasmic reticulum,
plasma membranes, and cytosol can pro-
vide insight into the potential effects of a
toxicant on a particular site within sub-
cellular structures or upon protein traf-
ficking or signaling pathways. 
Proteomics platforms appear particular-
ly well suited for biomarker development
in blood because the appearance of new
polypeptides in the serum proteome may
reveal early-stage disease and organ toxici-
ty. In the biofluids produced by each
organ, serum and plasma proteomes of
blood can uniquely reveal signs of specific
organ toxicity or pathology from the pep-
tides and proteins passively leaked or
actively secreted during dysfunction. In
addition, blood carries the nutrients, inter-
mediary metabolites, amino acids, pep-
tides, proteins, and enzymes necessary for
organ health, adaptation, and repair of
organ toxicity. Such blood-transported
biomaterials may arise from other body tis-
sues as well as from alimentary absorption.
Analysis of serum or plasma alone pre-
sents a challenge in separation and detec-
tion of informative proteins due to the
adundance of other serum proteins such
as albumin, immunoglobulins, and trans-
ferrin. NCT researchers are using
immunoaffinity and ligand-affinity
columns to remove such numerous and
noninformative serum constituents—
which comprise almost 90% of serum—
to allow for separation and identification
of the remaining 10% of informative
serum proteins.
Strategies
NCT researchers in the Proteomics
Program are in the process of developing
and refining strategies for integrating toxi-
cogenomics and toxicoproteomics data. 
Often the first analysis is a comparison
of altered genes from a DNA microarray
of liver with the profile of altered liver
proteins after two-dimensional gel separa-
tion and MS identification of proteins.
Annotated gene products and proteins
and their accession numbers, assigned by
GenBank, are searched for concordance to
identify unknown products. A second
analysis can involve determining the
affected pathways that contain common
altered gene transcripts and proteins rep-
resenting pathway activation or repres-
sion. A third analysis involves comparison
of proteins altered post-translationally
after toxicant exposure with specific gene
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phosphorylases, conjugating enzymes, and
other enzymes that target specific proteins
for modification. This can help to identify
gene expression. 
Another analysis can be performed by
kinetically profiling protein changes in
the serum proteome over the course of
pretoxic, toxic, and recovery stages of
chemical exposure. Such changes in the
serum proteome represent the dynamic
relationship between target organ toxicity
and blood during toxicity response,
repair, and recovery. 
Studies conducted with various
hepatotoxicant chemicals will examine
the hypothesis that gene and protein pro-
files can distinguish toxicants acting at
different areas of the functional liver lob-
ule. Toxicoproteomics will eventually
link the protein expression patterns of
multiple organ systems involved in toxi-
cant action and should contribute to a
better understanding of mechanisms of
toxicity to produce useful biomarkers of
environmental disease. –B. Alex Merrick
and Kenneth B. Tomer
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Strategies for Analysis of Toxicoproteomic Data
Analysis 1. Comparison of gene
alterations in toxicant-exposed ani-
mals obtained from DNA microarray
analysis of liver with the profile of
altered liver proteins obtained
through two-dimensional gel sepa-
ration and MS identification of pro-
teins. Annotated gene products and
proteins and their accession num-
bers are searched in GenBank to
identify unknown products.
Analysis 2. Comparison of DNA
microarray analysis of common
altered gene transcripts and profile
of altered proteins to determine
pathway activation or repression.
Analysis 3. Comparison of post-
translational modification of pro-
teins with gene transcript changes
in kinases, proteases, phosphory-
lases, conjugating enzymes, and
other enzymes to identify gene
expression.
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Analysis 4. Separation and identification
of informative serum or plasma proteins
in blood from other biofluids for bio-
markers of disease and organ toxicity.
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